TY - CHAP M1 - Book, Section TI - Addition of atezolizumab to FOLFOXIRI and bevacizumab led to limited increase in survival in metastatic colorectal cancer A1 - Pushani, Johan A1 - Chan, Samuel Y1 - 2015 N1 - T2 - 2 Minute Medicine AB - SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=594487 ER -